AGITATION,PSYCHOMOTOR
Clinical trials for AGITATION,PSYCHOMOTOR explained in plain language.
Never miss a new study
Get alerted when new AGITATION,PSYCHOMOTOR trials appear
Sign up with your email to follow new studies for AGITATION,PSYCHOMOTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for calming Alzheimer's agitation: new drug shows promise in Long-Term trial
Symptom relief CompletedThis study tested a drug called AXS-05 to see if it is safe and effective for treating agitation in people with Alzheimer's disease over a long period. 456 participants who had already been in earlier studies took the drug, and some later switched to a placebo to see if symptoms …
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 08, 2026 12:04 UTC
-
New pill aims to calm agitation at home for schizophrenia and bipolar patients
Symptom relief CompletedThis study tested an investigational medication called BXCL501 for calming agitation episodes in people with bipolar disorder, schizophrenia, or related conditions. 452 adults took either the drug or a placebo, and researchers measured changes in agitation levels and safety. The …
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: PHASE3 • Sponsor: BioXcel Therapeutics Inc • Aim: Symptom relief
Last updated May 06, 2026 16:03 UTC
-
New study examines Igalmi's effects after repeated use for agitation
Knowledge-focused CompletedThis study looked at what happens when people with schizophrenia or bipolar disorder take Igalmi repeatedly for agitation over 7 days, and then stop. Researchers wanted to see if the drug becomes less effective (tolerance) or causes withdrawal symptoms. 29 adults participated in …
Matched conditions: AGITATION,PSYCHOMOTOR
Phase: PHASE4 • Sponsor: BioXcel Therapeutics Inc • Aim: Knowledge-focused
Last updated May 17, 2026 10:49 UTC